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Attempts to cocrystallize the cysteine protease papain derived from the latex of
Carica papaya with an inhibitor of cysteine proteases (ICP) from Trypanosoma
brucei were unsuccessful. However, crystals of papain that diffracted to higher
resolution, 1.5 A ˚ , than other crystals of this archetypal cysteine protease were
obtained, so the analysis was continued. Surprisingly, the substrate-binding cleft
was occupied by two short peptide fragments which have been assigned as
remnants of ICP. Comparisons reveal that these peptides bind in the active site
in a manner similar to that of the human cysteine protease inhibitor steﬁn B
when it is complexed to papain. The assignment of the fragment sequences is
consistent with the speciﬁcity of the protease.
1. Introduction
The ﬁrst cysteine protease structure to be determined was that of
papain from Carica papaya. Since its discovery, many ‘papain-like’
proteases, also referred to as thiol or sulfhydryl peptidases, have been
characterized and are classiﬁed as clan CA proteases. The cysteine
proteases are grouped into seven clans deﬁned according to the linear
organization ofcatalytic residues in thesequence, e.g. clan CAhas the
catalytic residues Cys, His and Asn or Asp ordered in sequence, clan
CD presents two catalytic residues, His and Cys, in sequence, clan CE
has a triad formed by His, Glu or Asp and Cys at the C-terminus, clan
CF also presents a catalytic triad, but ordered as Glu, Cys and His,
clan CG has a dyad of two cysteine residues and clan CH presents a
Cys, Thr and His triad with the catalytic cysteine at the N-terminus
(Rawlings et al., 2006). Additionally, clan membership depends upon
speciﬁcity, with clan CA proteases characterized by sensitivity to the
inhibitor E64 [l-trans-epoxysuccinyl-leucyl-amido-(4-guanidino)-
butane] and by having substrate speciﬁcity deﬁned by the S2 pocket
(Sajid & McKerrow, 2002). The majority of protozoan parasite
cysteine proteases belong to clan CA family C1 papain-like proteases.
This family of parasite-derived cysteine peptidases are critical to the
life cycle or pathogenicity of many parasites, where they contribute
key roles in immunoevasion, enzyme activation, pathogenesis, viru-
lence and tissue and cellular invasion as well as excystment, hatching
and moulting, and are considered to be promising chemotherapeutic
targets (Sajid & McKerrow, 2002; Mottram et al., 2004).
The actions of mammalian cysteine proteases are controlled in part
by endogenous tight-binding inhibitors from the cystatin superfamily
(Grzonka et al., 2001; Abrahamson et al., 2003). The Leishmania
genome lacks genes encoding cystatins. However, in Trypanosoma
cruzi a potent inhibitor of the parasite’s own cysteine protease
cruzipain was identiﬁed and called chagasin (Besteiro et al., 2004).
Subsequently, several homologues of these inhibitors of cysteine
proteases (ICPs) were identiﬁed in the parasitic protozoa T. brucei,
L. major and L. mexicana and the bacterium Pseudomonas aerugi-
nosa (Sanderson et al., 2003). ICPs inhibit clan CA family C1 cysteine
proteases with varying speciﬁcities. The molar ratio of inhibition is 1:1
and inhibition is competitive. The ICP of T. brucei (TbICP) appears
to be more potent than the L. mexicana ICP and displays low
nanomolar Ki values against the clan CA family. Whilst ICPs share
low sequence homologies and no signiﬁcant identity with cystatins or
other cysteine protease inhibitors, their functional homology implies
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proteins (Sanderson et al., 2003).
We set out to cocrystallize the TbICP–papain complex, seeking to
generate structural data on an ICP and to understand the mode of
inhibition. Here, we report the resulting papain structure with ICP-
derived peptide fragments bound within the active-site cleft.
2. Methods and materials
2.1. Sample preparation
The gene encoding TbICP was previously cloned into plasmid
pBP117 (Sanderson et al., 2003), which produces recombinant protein
carrying an N-terminal histidine tag. This plasmid was heat-shock
transformed into Escherichia coli strain BL21(DE3). Cells were
grown in Luria–Bertani medium supplemented with ampicillin
(100 mgl
 1) to an optical density of 0.7. The culture was cooled to
288 K, gene expression was induced with 0.2 mM isopropyl -d-
thiogalactopyranoside and cell growth was continued overnight. Cells
were harvested by centrifugation (2500g) at 277 K, resuspended in
binding buffer (25 mM Tris–HCl pH 7.5, 500 mM NaCl, 5 mM
imidazole) and lysed using a OneShot cell disrupter (Constant
Systems). Insoluble debris was separated by centrifugation (40 000g)
at 277 K for 20 min and the supernatant was ﬁltered through a
0.45 mm syringe ﬁlter and then applied onto an Ni
2+-resin column
(GE Healthcare) pre-equilibrated with binding buffer using a
BioCAD 700e (Perseptive Biosystems). The resin was washed with
25 mM Tris–HCl, 10 mM imidazole pH 7.5 and the product was
eluted with an increasing imidazole gradient. Fractions were analyzed
by SDS–PAGE and those containing TbICP were pooled and
dialysed overnight against 25 mM Tris–HCl pH 7.5 in the presence of
80 units of thrombin (Amersham). The resulting mixture was ﬁltered
(0.45 mm) and applied onto a ResourceQ anion-exchange column
(Amersham). TbICP does not bind to this column, whilst thrombin
and the cleaved histidine-tag fragment do. Fractions containing
TbICP were pooled, dialyzed overnight against 25 mM Tris–HCl pH
7.5 at 277 K and then concentrated to 3.4 mg ml
 1.
2.2. Crystallization and data collection
Puriﬁed TbICP was mixed with papain (Sigma–Aldrich) to ﬁnal
concentrations of 1.4 mg ml
 1 (TbICP) and 2 mg ml
 1 (papain) in
25 mM Tris–HCl pH 7.5. This mixture was used in hanging-drop
crystallization trials with commercially available screens. No crystals
or promising conditions were identiﬁed over a period of several
months and the conditions were set aside at room temperature.
Following storage for 2 y, a crystal was observed in conditions that
were originally established by combining 1 ml protein mixture with
1 ml of a reservoir consisting of 50% ethanol, 0.01 M sodium acetate.
The crystal was cooled in a stream of nitrogen to 103 K and used for
data collection on beamline ID29 of the European Synchrotron
Radiation Facility, Grenoble. The orthorhombic crystal diffracted to
1.5 A ˚ . A data set comprising 360 images, each of 1  oscillation, were
collected, processed with MOSFLM (Leslie, 1992) and scaled using
SCALA (Collaborative Computational Project, Number 4, 1994) with
details presented in Table 1. At this stage the composition of the
crystal was unknown, but since the crystallization conditions resem-
bled those previously reported for papain (Kamphuis et al., 1984) and
the unit-cell parameters are similar to those reported for an ortho-
rhombic crystal form of the enzyme, albeit with a 5% difference in
unit-cell lengths, we thought it likely that papain itself had been
crystallized. The Matthews coefﬁcient calculated for one molecule
per asymmetric unit of papain was 2.2 A ˚ 3 Da
 1, with 44% solvent
content. However, since the diffraction data extended to slightly
higher resolution than the best resolved data available for this
protease (structures in the PDB fall in the range 2.8–1.6 A ˚ resolu-
tion), we continued with the analysis.
2.3. Structure determination and model refinement
Molecular replacement (MOLREP; Vagin & Teplyakov, 2000)
using the papain model with PDB code 9pap (Kamphuis et al., 1984)
produced a solution with an R factor of 38% and a correlation
coefﬁcient of 0.64. Rigid-body reﬁnement (REFMAC5; Murshudov et
al., 1997) and further restrained reﬁnement interspersed with model
building, adjustment and water placement using COOT (Emsley &
Cowtan, 2004) resulted in a complete model with an R factor of
17.6% and an Rfree of 22.5%. The Rmerge for data in the highest
resolution range exceeded 60%. In general, we would not normally
use such data but, given that the hI/(I)i value was nearly 4 for this
resolution bin and with high redundancy approaching 14, we were
content to include these diffraction terms and trust the beneﬁts of
maximum-likelihood weighting (Murshudov et al., 1997). The
approach appears to have been successful given that the statistics (R
factor = 22.0%, Rfree = 29.4%) for the highest resolution data are
acceptable.
The completed model comprises residues 1–212 and 161 waters.
Eight residues (76–79 and 193–196) are relatively poorly deﬁned in
the electron-density maps and 17 (3, 9, 13, 21, 34, 70, 73, 74, 84, 91, 98,
99, 133, 145, 155, 173 and 197) are modelled in dual conformations.
Residues 35, 118 and 135 are all assigned as glutamine in the starting
model (PDB code 9pap), but on the basis of hydrogen-bonding
considerations our model contains glutamic acid at these positions, a
point discussed below. In addition to acetate (included in the crys-
tallization conditions), glycerol (likely to have been acquired from
the dialysis tubing) and the three O atoms bound to the active-site
cysteine, which is in the form of sulfonic acid, two short peptide
fragments have been modelled into the active-site cleft. It is likely
that these are remnants of the TbICP that was mixed with papain
prior to crystallization. The geometry of this high-resolution model
was acceptable, with all residues in the most favourable or allowed
regions of the Ramachandran plot (Table 1).
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Table 1
Crystallographic statistics.
Values in parentheses represent the highest resolution bin of approximate width 0.08 A ˚ .
Space group P212121
Unit-cell parameters (A ˚ ) a = 42.32, b = 46.12, c = 95.70
Resolution range (A ˚ ) 96–1.5
No. of observed/unique reﬂections 418881/60928
Wilson B (A ˚ 2) 16.24
Completeness (%) 100 (100)
Multiplicity 13.6 (13.8)
Rmerge (%) 9.5 (62.9)
Mean hI/(I)i 21.4 (3.7)
R factor/Rfree (%) 17.67 (22.0)/22.54 (29.4)
R.m.s.d. from ideal values, bond lengths (A ˚ ) 0.013
R.m.s.d. from ideal values, bond angles ( ) 1.416
Average B values (A ˚ 2)
Overall 17.9
Main chain 16.9
Side chain 18.9
Waters 34.4
Fragment I 38.1
Fragment II 35.1
Ramachandran analysis
Residues in most favourable regions (%) 88.4
Residues in additional allowed regions (%) 11.6
DPI† (A ˚ ) 0.25
† Diffraction precision indicator (Cruickshank, 1999).3. Results
3.1. Overall structure
The structure of papain has been well characterized (Drenth et al.,
1976; Kamphuis et al., 1984; Pickersgill et al., 1992; Tsuge et al., 1999).
The protein is assembled from two domains, each comprising residues
from both the N- and C-terminal sections of the polypeptide. One
domain consists of a six-stranded antiparallel -sheet and the other
domain consists mainly of three -helices. The elongated active-site
cleft is formed between them and is lined by residues from both
domains. The active-site Cys25 is positioned at the N-terminus of 1
and is likely to be inﬂuenced by the helix dipole. As noted from
previous structural studies on papain (Kamphuis et al., 1984), this
cysteine has been oxidized to sulfonic acid, probably owing to the
highly reactive nature of the thiol group in the active enzyme.
Our model is essentially identical to published structures of papain
with r.m.s.d. values determined by overlaying C
 positions of 0.41 A ˚
(PDB code 1stf; Stubbs et al., 1990), 0.32 A ˚ (9pap; Kamphuis et al.,
1984), 0.38 A ˚ (1bp4; LaLonde et al., 1998), 0.46 A ˚ (1bqi; LaLonde et
al., 1998), 0.30 A ˚ (1cvz; Tsuge et al., 1999), 0.32 A ˚ (1khq; Janowski et
al., 2004), 0.35 A ˚ (1pip; Yamamoto et al., 1992) and 0.32 A ˚ (1pe6;
Yamamoto et al., 1991). There are minor differences owing to the
ﬂexibility of surface residues Arg41, Gln73, Arg98, Glu99, Arg111,
Gln114, Arg145 and Lys156. The N-terminus (Glu3) and C-terminus
(Asn212) also exhibit some ﬂexibility and the electron density in
these regions is not as well deﬁned as for the rest of the molecule.
In all but three of the deposited papain structures (1khp, 1khq and
1ppn), residues 35, 118 and 135 are assigned as glutamine. Using the
hydrogen-bonding networks as a guide, we assign these residues as
glutamic acid and as an example show Glu118 in Fig. 1. Glu118 OE1
accepts hydrogen bonds donated from the backbone amide of Gly192
and the hydroxyl of Tyr203, whilst Glu118 OE2 accepts a hydrogen
bond from Arg191 NH1. The carboxylate side chain of Glu135
participates in a three-centre hydrogen bond with the amide of Gly54.
The distances between the OE1 and OE2 atoms and Gly54 N are 3.07
and 3.09 A ˚ , respectively. Glu35 OE2 accepts a hydrogen bond
donated from theamide ofTyr48 anda water molecule; OE1 interacts
with two water molecules and the side-chain hydroxyl of Thr14. This
hydroxyl group accepts hydrogen bonds from NZ of Lys17 and
Lys174, thus deﬁning that it must donate a hydrogen bond to
Glu35 OE1.
Inearly amino-acid sequences of papain, residues 118 and 135 were
initially assigned as glutamic acids, but on the basis of a re-evaluation
of the sequence were changed to glutamine (Mitchel et al., 1970). It is
possible that there is variation in papain sequences depending upon
the exact source of the enzyme. We note that only small structural
perturbations would occur if the hydrogen-bonding patterns were to
be altered by incorporation of glutamines at these positions in the
sequence.
3.2. The active site and peptide fragments
We were unable to crystallize a papain–TbICP complex and
conclude that during storage digestion of TbICP has occurred and the
protease has crystallized with two peptide fragments bound in the
active site (Fig. 2). Papain is a relatively promiscuous protease
releasing an array of peptide fragments and it is possible that a
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Figure 1
An omit difference electron-density map for Glu118 calculated with coefﬁcients
(Fo   Fc) and contoured at 3 (magenta) revealing the hydrogen-bonding (yellow
dashed lines) pattern that deﬁnes the side-chain properties. Fo and Fc represent the
observed and calculated structure factors, respectively. The reﬁned model is shown
in sticks with O atoms in red, N atoms in blue and C atoms in white. All ﬁgures were
prepared using PyMOL (DeLano, 2002).
Figure 2
Molecular-surface representation of the papain active site showing the position of
the catalytic Cys25 (yellow) and the two peptide fragments (sticks coloured C
orange, O red, N blue) with associated omit difference electron-density (Fo   Fc)
map contoured at 1.5 (magenta).
Figure 3
Selected active-site details. Putative hydrogen-bonding interactions (green dashed
lines) between papain (sticks coloured C black, O red, N blue, S yellow) and the
peptide fragments derived from TbICP (sticks coloured C orange, O red, N blue)
are depicted. The OD1, OD2 and OD3 atoms associated with the sulfonic acid
group of Cys25 are labelled 1, 2 and 3, respectively; water molecules are shown as
red spheres and labelled W.mixture of such fragments occupy the active site. However, careful
inspection of electron-density and difference-density maps, taking
into consideration the amino-acid sequence of TbICP, has allowed us
to model fragment I as the dipeptide Gly-Gly (corresponding to
residues Gly78-Gly79 of TbICP). Fragment II has been modelled as a
tripeptide Leu-Ser-Leu which corresponds to Leu95-Ser96-Leu97 of
TbICP. The dipeptide occupies the S subsite and the tripeptide is
placed in the S0 subsite of papain. The active-site Cys25 is modiﬁed by
covalent attachment of three O atoms, as mentioned previously, and
the position of each allows a number of activating and stabilizing
interactions with surrounding residues and also the two short peptide
fragments bound in the active-site cleft. Selected interactions are
depicted in Fig. 3.
Gly10 (0 and 00 denote fragments I and II, respectively) is positioned
in a hydrophobic region of the active-site cleft surrounded by Trp69,
Val133 and Phe207, with Pro68 at the base of the cleft (not shown).
The Gly10 amide forms two hydrogen bonds with water molecules
(Fig. 3). Gly20 is placed near Ala160 and its carbonyl O is within
hydrogen-bonding distance of the main-chain amide of Gly66 and
Cys25 OD1. The latter association suggests that Cys25 OD1 repre-
sents the hydroxyl group of the sulfonic acid, an assignment consis-
tent with the other interactions observed with the modiﬁed Cys25.
The Cys25 OD2 group accepts hydrogen bonds from Gln19 NE2 and
the amino-terminus of fragment II, the Leu100 amide, while
Cys25 OD3 interacts with His159 ND1 and the Ala160 amide.
His159, part of the protease catalytic triad, is held in position by
Asn175 and is 5.4 A ˚ distant from the side chain of Asp158, tradi-
tionally considered to be the third member of the triad (not shown).
Both Asn175 and His159 have low B factors, 14 and 11 A ˚ 2, respec-
tively, whilst the B factor for Asp158 is around 20 A ˚ 2. There has been
discussion in the literature on whether the catalytic triad for papain is
Cys25–His159–Asp158 or alternatively Cys25–His159–Asn175 (Wang
et al., 1994). However, it has been shown that Asn175 is not essential
for enzyme activity and is more likely to be involved in enzyme
stability and orientation of the catalytic His159 (Vernet et al., 1995).
In addition to its interactions with His159, Cys25 is held in position
through interactions of its carbonyl group with the backbone amides
of Phe28 and Ser29.
The amino end of fragment II is held in place by hydrogen bonds
donated to Cys25 OD3 and the carbonyl group of Asp158. The Leu100
carbonyl group accepts a hydrogen bond donated from Trp177 NE1,
whilst the side chain nestles comfortably in a pocket created mainly
by the side chains Ala137, Gln142, Asp158 and Trp177. Ser200 is
solvent accessible and does not make any direct hydrogen bonds to
the protein. The Leu300 side chain binds in a hydrophobic patch
created by Trp177 and Trp181, whilst the amide group interacts with a
water molecule. The fragment II carboxylate group interacts with
Gln142 OE1, suggesting that it is protonated. Gln142 NE2 donates a
hydrogen bond to the carbonyl group of Ala136.
Comparison of the structure reported here with the complex
formed between papain and the protease inhibitor human cystatin
steﬁn B (Stubbs et al., 1990) was carried out by overlaying papain.
This indicates that the positions of the bound peptide fragments
closely resemble the positions of the cleft-binding N-terminus and
ﬁrst loop of steﬁn B (Fig. 4). The direction of the steﬁn B polypeptide
is consistent with that observed for fragments I and II.
We have assigned the fragments described in this study to products
of TbICP digestion with sequences deﬁned solely on the basis of
interpreting the electron density and on successful reﬁnement. For
fragment I, two glycine residues corresponding to Gly78-Gly79 were
assigned. This agrees with a theoretical model of L. mexicana ICP
(LmICP) bound to papain which places the inhibitor BC loop in the S
subsite (Smith et al., 2006) and suggests that this part of the papain
active-site cleft can accept small side chains. Alignment of the two
ICP sequences places a Gly76-Ala77-Gly78-Gly79 motif of TbICP
alongside the BC loop of LmICP (data not shown).
It is noteworthy that in the description of papain activity provided
by the commercial supplier of the enzyme, Sigma–Aldrich, the
enzyme is deﬁned as having activity towards the peptide bonds of
basic residues, leucine or glycine. Our observation and assignment of
the peptide fragments bound in the active site is consistent with such
a deﬁnition.
We thank Graham Coombs and Jeremy Mottram for discussions
and provision of the expression system for TbICP, Charles Bond and
Mads Gabrielsen for advice, staff at the European Synchrotron
Radiation Facility for support and the Wellcome Trust and BBSRC
for funding.
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